FDA OKs Zolbetuximab for Gastric, Gastroesophageal Cancer

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

This FDA approval marks the first for a claudin 18.2–targeting agent in the United States.
Medscape Medical News